Rohto Pharmaceutical Co Ltd (RPHCF)
OTHER OTC:RPHCF
US Market
Advertisement

Rohto Pharmaceutical Co (RPHCF) Ratios

Compare
3 Followers

Rohto Pharmaceutical Co Ratios

RPHCF's free cash flow for Q1 2026 was ¥0.56. For the 2026 fiscal year, RPHCF's free cash flow was decreased by ¥ and operating cash flow was ¥0.14. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
2.54 2.47 2.47 2.37 2.30
Quick Ratio
1.79 1.93 1.93 1.86 1.83
Cash Ratio
0.89 1.02 1.02 1.00 1.02
Solvency Ratio
0.32 0.40 0.40 0.36 0.32
Operating Cash Flow Ratio
0.00 0.39 0.39 0.39 0.38
Short-Term Operating Cash Flow Coverage
0.00 6.46 6.46 7.40 3.39
Net Current Asset Value
¥ 70.89B¥ 115.62B¥ 115.62B¥ 95.64B¥ 73.51B
Leverage Ratios
Debt-to-Assets Ratio
0.11 0.03 0.03 0.04 0.08
Debt-to-Equity Ratio
0.18 0.04 0.04 0.06 0.12
Debt-to-Capital Ratio
0.15 0.04 0.04 0.05 0.11
Long-Term Debt-to-Capital Ratio
0.14 0.02 0.02 0.03 0.07
Financial Leverage Ratio
1.61 1.41 1.41 1.48 1.54
Debt Service Coverage Ratio
5.14 7.32 7.32 7.57 3.50
Interest Coverage Ratio
32.21 204.33 204.33 137.49 118.34
Debt to Market Cap
0.09 0.02 0.02 0.02 0.05
Interest Debt Per Share
218.69 46.86 46.86 52.34 94.81
Net Debt to EBITDA
-0.52 -1.56 -1.56 -1.65 -1.44
Profitability Margins
Gross Profit Margin
56.18%58.07%58.07%57.58%58.35%
EBIT Margin
12.36%15.40%15.40%14.47%14.09%
EBITDA Margin
16.19%18.61%18.61%17.32%17.94%
Operating Profit Margin
12.00%14.79%14.79%14.23%14.70%
Pretax Profit Margin
14.06%15.33%15.33%14.37%14.00%
Net Profit Margin
10.64%11.42%11.42%11.05%10.58%
Continuous Operations Profit Margin
10.71%11.59%11.59%11.07%10.61%
Net Income Per EBT
75.68%74.51%74.51%76.92%75.58%
EBT Per EBIT
117.23%103.67%103.67%100.97%95.24%
Return on Assets (ROA)
8.01%8.94%8.94%8.52%7.69%
Return on Equity (ROE)
13.24%12.56%12.56%12.59%11.85%
Return on Capital Employed (ROCE)
11.25%15.46%15.46%14.80%14.45%
Return on Invested Capital (ROIC)
8.41%11.64%11.64%11.20%10.52%
Return on Tangible Assets
9.51%9.18%9.18%8.79%7.96%
Earnings Yield
6.34%4.51%4.51%4.17%5.01%
Efficiency Ratios
Receivables Turnover
7.21 3.92 3.92 3.93 3.86
Payables Turnover
6.72 5.38 5.38 5.41 5.11
Inventory Turnover
2.24 2.43 2.43 2.47 2.48
Fixed Asset Turnover
3.65 3.95 3.95 3.61 3.18
Asset Turnover
0.75 0.78 0.78 0.77 0.73
Working Capital Turnover Ratio
2.54 2.28 2.28 2.35 2.36
Cash Conversion Cycle
159.62 175.22 175.22 173.32 170.24
Days of Sales Outstanding
50.62 93.14 93.14 92.76 94.49
Days of Inventory Outstanding
163.27 149.97 149.97 148.04 147.16
Days of Payables Outstanding
54.28 67.90 67.90 67.48 71.41
Operating Cycle
213.90 243.11 243.11 240.80 241.65
Cash Flow Ratios
Operating Cash Flow Per Share
0.00 150.11 150.11 135.55 119.44
Free Cash Flow Per Share
0.00 111.04 111.04 92.12 69.79
CapEx Per Share
0.00 39.06 39.06 43.43 49.65
Free Cash Flow to Operating Cash Flow
0.00 0.74 0.74 0.68 0.58
Dividend Paid and CapEx Coverage Ratio
0.00 2.38 2.38 2.12 1.85
Capital Expenditure Coverage Ratio
0.00 3.84 3.84 3.12 2.41
Operating Cash Flow Coverage Ratio
0.00 3.26 3.26 2.64 1.27
Operating Cash Flow to Sales Ratio
0.00 0.13 0.13 0.13 0.14
Free Cash Flow Yield
0.00%3.70%3.70%3.33%3.78%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
15.71 22.15 22.15 23.96 19.95
Price-to-Sales (P/S) Ratio
1.65 2.53 2.53 2.65 2.11
Price-to-Book (P/B) Ratio
2.02 2.78 2.78 3.02 2.36
Price-to-Free Cash Flow (P/FCF) Ratio
0.00 27.05 27.05 30.07 26.47
Price-to-Operating Cash Flow Ratio
0.00 20.01 20.01 20.44 15.47
Price-to-Earnings Growth (PEG) Ratio
1.43 1.28 1.28 0.96 0.76
Price-to-Fair Value
2.02 2.78 2.78 3.02 2.36
Enterprise Value Multiple
9.67 12.04 12.04 13.64 10.33
Enterprise Value
506.43B 606.61B 606.61B 563.69B 370.08B
EV to EBITDA
9.71 12.04 12.04 13.64 10.33
EV to Sales
1.57 2.24 2.24 2.36 1.85
EV to Free Cash Flow
0.00 23.95 23.95 26.82 23.24
EV to Operating Cash Flow
0.00 17.71 17.71 18.23 13.58
Tangible Book Value Per Share
945.32 1.04K 1.04K 900.83 765.04
Shareholders’ Equity Per Share
1.16K 1.08K 1.08K 918.60 781.47
Tax and Other Ratios
Effective Tax Rate
0.24 0.24 0.24 0.23 0.24
Revenue Per Share
1.41K 1.19K 1.19K 1.05K 875.10
Net Income Per Share
149.74 135.60 135.60 115.62 92.61
Tax Burden
0.76 0.75 0.75 0.77 0.76
Interest Burden
1.14 1.00 1.00 0.99 0.99
Research & Development to Revenue
0.05 0.04 0.04 0.05 0.04
SG&A to Revenue
-0.12 0.17 0.17 0.00 0.00
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.00 1.11 1.11 0.90 0.97
Currency in JPY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis